Vycor Medical (VYCO) Cash from Investing Activities (2010 - 2026)

Vycor Medical (VYCO) has 17 years of Cash from Investing Activities data on file, last reported at $2140.0 in Q1 2026.

• On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to $2140.0 in Q1 2026; TTM through Mar 2026 was $704.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$4383.0, down 4.38% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at $2140.0, up from -$1606.0 in the prior quarter.
• Over the last five years, Cash from Investing Activities for VYCO reached as high as $2140.0 in Q1 2026 and fell as low as -$5904.0 in Q4 2023.
• Historically, Cash from Investing Activities has averaged -$1148.5 across 5 years, with a median of $170.0 in 2024.
• Across the five-year window, Cash from Investing Activities plunged 4291.67% in 2023 and surged 129.86% in 2024, its largest moves.
• Year by year, Cash from Investing Activities stood at $322.0 in 2022, then tumbled by 1933.54% to -$5904.0 in 2023, then jumped by 102.88% to $170.0 in 2024, then slumped by 1044.71% to -$1606.0 in 2025, then soared by 233.25% to $2140.0 in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were $2140.0 in Q1 2026, -$1606.0 in Q4 2025, and $170.0 in Q4 2024.